Semaglutide ameliorates diabetes-associated cognitive dysfunction in mouse model of type 2 diabetes

Semaglutide ameliorates diabetes-associated cognitive dysfunction in mouse model of type 2 diabetes

Saved in:

Bibliographic Details
Main Authors:	Yan Zhu, Yi He, Hongyan Yang, Yanbo Gao, Yan Wang, Peiqing Liu, Mengjuan Zhang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12225814/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Semaglutide Ameliorates Diabetic Neuropathic Pain by Inhibiting Neuroinflammation in the Spinal Cord
by: Sing-Ong Lee, et al.
Published: (2024-11-01)

Effects of Semaglutide on CKD in Patients With Type 2 Diabetes
by: Sradha S. Kotwal, et al.
Published: (2025-02-01)

Oral semaglutide: the innovation in type 2 diabetes management
by: M. V. Shestakova, et al.
Published: (2021-09-01)

Comparative cardiovascular outcomes of semaglutide to dulaglutide in patients with type 2 diabetes
by: Takefumi Kishimori, et al.
Published: (2025-07-01)

Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice
by: Fang Lv, et al.
Published: (2024-12-01)

Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes
by: Jorge Rico-Fontalvo, et al.
Published: (2024-07-01)

SGK1 drives hippocampal demyelination and diabetes-associated cognitive dysfunction in mice
by: Ziying Jiang, et al.
Published: (2025-02-01)

Semaglutide and High-Intensity Interval Exercise Attenuate Cognitive Impairment in Type 2 Diabetic Mice via BDNF Modulation
by: Sijie Lai, et al.
Published: (2025-05-01)

Peripheral mitochondrial transplantation alleviates diabetes-associated cognitive dysfunction by suppressing cuproptosis
by: Juan Hu, et al.
Published: (2025-03-01)

S-9-PAHSA ameliorates cognitive decline in a type 2 diabetes mouse model by inhibiting oxidative stress and apoptosis via CAIII modulation
by: Xin-Ru Wang, et al.
Published: (2025-08-01)

Recommendations for Titration and Administration of Oral Semaglutide for the Treatment of Type 2 Diabetes during Ramadan
by: Mohamed Hassanein, et al.
Published: (2022-12-01)

Real‐World Persistence and Characteristics of Type 2 Diabetes Patients Prescribed Semaglutide in Scotland
by: David Alexander Dickie, et al.
Published: (2025-05-01)

The role of intermittent fasting in the treatment of cognitive dysfunction in type 2 diabetes mellitus
by: Chunying Cui, et al.
Published: (2025-05-01)

From Diabetes to Weight Loss: The Problems with Semaglutide's Expanded Use
by: Rawan Othman
Published: (2025-08-01)

Race of GLPS: Impact on Weight and Glycemic Control on Type 2 Diabetes with Semaglutide Versus Liraglutide
by: Noha Hafeez, et al.
Published: (2024-12-01)

Cardiovascular Outcomes of Semaglutide vs Dulaglutide in Nonobese Type II Diabetes Patients With HFpEF
by: Patrick A. Kwaah, MBChB, et al.
Published: (2025-07-01)

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
by: Barnaby Hunt, et al.
Published: (2019-05-01)

Association of semaglutide use with depressive symptoms and suicidal behavior in a patient with type 2 diabetes: A case report
by: Anisija Stojkovska, et al.
Published: (2025-07-01)

Retinal Thickness Associates with Cognition Dysfunction in Young Adult with Type 1 Diabetes in Taiwan
by: Jung-Lung Hsu, et al.
Published: (2022-01-01)

Association of Different Types of Diabetic Autonomic Neuropathy With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes: A Cross‐Sectional Study
by: Ruixue Feng, et al.
Published: (2025-07-01)

Linarin Ameliorates Aortic Endothelial Dysfunction in Diabetic Mice by Targeting Intelectin 1
by: LI Zicheng, MAO Aiqin, SHI Xiaoming, HE Dongxu
Published: (2025-04-01)

Ameliorative Effect of Parabacteroides distaxsonis on Cognitive Impairment Caused by Type 2 Diabetes Mellitus
by: DU Yue, ZHAO Zhongna, LIU Xuebo
Published: (2025-05-01)

Semaglutide in people with obesity and type 2 diabetes on hemodialysis: a prospective analysis of glycemic and weight outcomes
by: Akinori Hayashi, et al.
Published: (2025-05-01)

Effectiveness for adding or switching from other incretin‐related drugs to oral semaglutide in type 2 diabetes
by: Junko Oya, et al.
Published: (2025-04-01)

Insights into the Efficacy of GLP-1 Agonists and Dual Agonists: Semaglutide and Tirzepatide in Obesity and Type 2 Diabetes
by: Laura Opalska, et al.
Published: (2024-12-01)

A Mouse Model of Beta-Cell Dysfunction as Seen in Human Type 2 Diabetes
by: Jacqueline H. Parilla, et al.
Published: (2018-01-01)

Total Alkaloids of Rhizoma Corydalis regulates gut microbiota and restores gut immune barrier to ameliorate cognitive dysfunction in diabetic rats
by: Yazhi Qi, et al.
Published: (2024-12-01)

Semaglutide Inducing Resolution of Proliferative Diabetic Retinopathy: A Case Report
by: Daniel Cool, et al.
Published: (2024-01-01)

Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes
by: Shujun Zhang, et al.
Published: (2024-11-01)

Adropin ameliorates reproductive dysfunctions in letrozole-induced PCOS mouse
by: Shweta Maurya, et al.
Published: (2025-03-01)

Commiphora gileadensis ameliorate infertility and erectile dysfunction in diabetic male mice
by: Alhazmi Ayman Saeed
Published: (2025-03-01)

Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial.
by: Yu-Hao Lin, et al.
Published: (2024-01-01)

Subclinical Changes in Type 2 Diabetes Patients with Heart Failure Stage A and B Treated with Oral Semaglutide
by: Larissa Dăniluc, et al.
Published: (2025-03-01)

Acute pancreatitis and euglycemic non-diabetic ketoacidosis caused by an intentional semaglutide overdose
by: Anthony Acosta, et al.
Published: (2025-03-01)

Diffuse Podocytopathy Associated With Semaglutide
by: Rose Mary Attieh, et al.
Published: (2024-05-01)

ROLE OF NEUROSPECIFIC PROTEINS IN THE DEVELOPMENT OF COGNITIVE DYSFUNCTION IN PATIENTS WITH TYPE 1 DIABETES
by: M. V. Novosyolova, et al.
Published: (2014-04-01)

The Role of Insulin Deficiency in Cognitive Dysfunction in Patients with Type 1 Diabetes Mellitus
by: Yu. V. Bykov
Published: (2024-06-01)

Regulation of intestinal flora by Suaeda salsa extract ameliorates hyperglycemia in a mouse model of type 2 diabetes mellitus
by: Xuemei Yin, et al.
Published: (2024-12-01)

Association of Monocyte-to-HDL Cholesterol Ratio with Endothelial Dysfunction in Patients with Type 2 Diabetes
by: Huihui Zhang, et al.
Published: (2024-01-01)

Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review
by: Åke Sjöholm, et al.
Published: (2025-04-01)